Table 2.

Bioengineering strategies to modify characteristics of therapeutic hemostatic proteins

Bioengineering strategies to modify characteristics of therapeutic hemostatic proteins
View large
Bioengineering strategies to modify characteristics of therapeutic hemostatic proteins

PSA indicates polysialic acid; FcRn, neonatal Fc receptor; and PTMs, posttranslational modifications.

*Not discussed in text.

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal